Prelude Therapeutics Incorporated
PRLD
|
$4.16
-15.28%
-18.03%
69K
|
Health Technology
(0.0% 1d) (-13.6% 1m) (-36.1% 1y) (0.0% 2d) (-14.9% 3d) (-25.6% 7d) (79.61% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 228,469,671
http://www.preludetx.com
Sec Filling | Patents | 68 employees
Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
cancer drug discovery msa
add to watch list Paper trade email alert is off
Press-releases
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
Published: 2024-04-09 (Crawled : 21:00) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -3.41%
H: 7.26%
C: 2.7%
meeting
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: 1.45%
H: 5.7%
C: -0.95%
preclinical meeting
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -0.23%
H: 8.04%
C: 6.99%
conference global therapeutics
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024
Published: 2024-02-15 (Crawled : 21:00) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: 0.57%
H: 35.71%
C: 32.29%
year key therapeutics financial results
Prelude Therapeutics Announces $25 Million Private Placement
Published: 2023-12-11 (Crawled : 14:30) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -0.89%
H: 4.5%
C: -0.9%
therapeutics
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -6.45%
H: 29.31%
C: 27.01%
partnership pipeline financial results
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
ABCL | $3.92 -3.21% -3.32% 1.1M
|
|
| O: 1.94%
H: 0.0%
C: 0.0%
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -6.45%
H: 29.31%
C: 27.01%
partnership drug antibody therapeutics
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference
Published: 2023-10-14 (Crawled : 20:20) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
| Email alert
Add to watchlist
preclinical
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September
Published: 2023-08-29 (Crawled : 12:30) - globenewswire.com
MS | News 0 d | $90.08 1.06% -0.28% 9.5M
|
Finance
|
| O: 0.64%
H: 0.0%
C: 0.0%
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -1.24%
H: 1.22%
C: -3.27%
therapeutics
Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
PRLD | $4.16 -15.28% -18.03% 69K
|
Health Technology
|
| O: -0.27%
H: 0.27%
C: -3.48%
update therapeutics financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001562180-24-002127 | 4 | 2024-03-04 | 2024-03-01 | Buy | A | 425000 | 425000 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10